EWG scientists reviewed La Roche-Posay Hydraphase - Hydraphase Eyes Hydrating Treatment Gel (2010 formulation) for safety according to the methodology outlined in our Skin Deep Cosmetics Database. We assess the ingredients listed on the labels of personal care products based on data in toxicity and regulatory databases, government and health agency assessments and the open scientific literature. EWG's rating for La Roche-Posay Hydraphase - Hydraphase Eyes Hydrating Treatment Gel (2010 formulation) is 5.
|RETINYL PALMITATE (VITAMIN A PALMITATE)||Biochemical or cellular level changes, Cancer, Developmental/reproductive toxicity, Organ system toxicity (non-reproductive), Use restrictions|
|POLYACRYLAMIDE||Ecotoxicology, Contamination concerns (ACRYLAMIDE), Organ system toxicity (non-reproductive), Persistence and bioaccumulation, Use restrictions|
|METHYLPARABEN||Biochemical or cellular level changes, Endocrine disruption, Allergies/immunotoxicity, Use restrictions|
|LAURETH-7||Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE), Use restrictions|
|SODIUM HYDROXIDE||Irritation (skin, eyes, or lungs), Organ system toxicity (non-reproductive), Use restrictions|
|CAFFEINE||Persistence and bioaccumulation|
|GLYCINE SOJA PROTEIN|
|SODIUM HYALURONATE||None Identified|
|DISODIUM EDTA||Enhanced skin absorption|
About the ratings
EWG provides information on personal care product ingredients from the published scientific literature, to supplement incomplete data available from companies and the government.
The ratings below indicate the relative level of concern posed by exposure to the ingredients in this product - not the product itself - compared to other product formulations. The ratings reflect potential health hazards but do not account for the level of exposure or individual susceptibility, factors which determine actual health risks, if any. Learn more
| Legal Disclaimer